JCO at ASCO Annual Meeting: Avelumab Plus Cetuximab vs. Avelumab in Advanced cSCC

<p><em>JCO</em> Editorial Fellow Dr. Ece Cali Daylan and <em>JCO</em> Associate Editor Dr. Grant McArthur discuss the ASCO 2025 Simultaneous Publication paper "<a href= "https://ascopubs.org/doi/10.1200/JCO-25-00759" target="_blank" rel="noopener">A Phase II (Alliance A091802) Randomized Trial of Avelumab Plus Cetuximab vs. Avelumab Alone in Advanced Cutaneous Squamous Cell Carcinoma (cSCC)</a>."</p> <h2>Transcript</h2> <p class="MsoNormal" style= "margin-bottom: 12.0pt; text-align: center; line-height: 200%;" align="center"><span style= "font-family: arial, helvetica, sans-serif;"><em style= "mso-bidi-font-style: normal;"><span lang="EN" xml:lang="EN">The guest on this podcast episode has no disclosures to declare.</span></em></span></p> <p class="MsoNormal" style="margin: 12.0pt 0in 12.0pt 0in;"> <span style= "font-family: arial, helvetica, sans-serif;"><strong>Dr. Ece Cali:</strong> Hello, and welcome to our 2025 ASCO Annual Meeting series where we cover some of the top JCO papers p...